| scholarly article | Q13442814 |
| P2093 | author name string | Ning Li | |
| Xiao Wang | |||
| Jianfei Chen | |||
| Ding Ma | |||
| Jianfeng Zhou | |||
| Danhui Weng | |||
| Ying Guo | |||
| Yanyan Zhao | |||
| Zheng Gu | |||
| Nan Ji | |||
| Jisheng Wang | |||
| Cang Liu | |||
| Zhong Fan | |||
| Shizhang Chen | |||
| P2860 | cites work | Phase I study of cytokine-gene modified autologous neuroblastoma cells for treatment of relapsed/refractory neuroblastoma | Q67987475 |
| HSV1716 injection into the brain adjacent to tumour following surgical resection of high-grade glioma: safety data and long-term survival | Q30954768 | ||
| Phase Ib trial of mutant herpes simplex virus G207 inoculated pre-and post-tumor resection for recurrent GBM | Q33712977 | ||
| Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma | Q33905047 | ||
| Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial | Q33905053 | ||
| The potential for efficacy of the modified (ICP 34.5(-)) herpes simplex virus HSV1716 following intratumoural injection into human malignant glioma: a proof of principle study | Q34124333 | ||
| A systematic comparison of the anti-tumoural activity and toxicity of the three Adv-TKs | Q35145614 | ||
| Management of raised intracranial pressure and hyperosmolar therapy | Q38183670 | ||
| Traumatic intracranial hypertension | Q38215544 | ||
| Novel permissive murine immunocompetent orthotopic colon carcinoma model for comparison of the antitumoral and safety profiles of three Adv-TKs | Q39135464 | ||
| A potent oncolytic adenovirus selectively blocks the STAT3 signaling pathway and potentiates cisplatin antitumor activity in ovarian cancer | Q39482713 | ||
| Phase I and biodistribution study of recombinant adenovirus vector-mediated herpes simplex virus thymidine kinase gene and ganciclovir administration in patients with head and neck cancer and other malignant tumors | Q40392477 | ||
| Thymidine kinase gene therapy for human malignant glioma, using replication-deficient retroviruses or adenoviruses | Q40611932 | ||
| Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: implications for clinical trials | Q40790899 | ||
| Hyperosmolar opening of the blood-brain barrier in the energy-depleted rat brain. Part 1. Permeability studies | Q41387008 | ||
| Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir | Q41576545 | ||
| Adenovirus-mediated gene therapy with sitimagene ceradenovec followed by intravenous ganciclovir for patients with operable high-grade glioma (ASPECT): a randomised, open-label, phase 3 trial | Q42284125 | ||
| A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-Attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant setting. | Q42639115 | ||
| Treatment of relapsed malignant glioma with an adenoviral vector containing the herpes simplex thymidine kinase gene followed by ganciclovir | Q44466935 | ||
| Beta-galactosidase gene transfer to human malignant glioma in vivo using replication-deficient retroviruses and adenoviruses | Q44654746 | ||
| Adenovirus/herpes simplex-thymidine kinase/ganciclovir complex: preliminary results of a phase I trial in patients with recurrent malignant gliomas. | Q44697885 | ||
| AdvHSV-tk gene therapy with intravenous ganciclovir improves survival in human malignant glioma: a randomised, controlled study | Q45127753 | ||
| Adjuvant adenovirus-mediated delivery of herpes simplex virus thymidine kinase administration improves outcome of liver transplantation in patients with advanced hepatocellular carcinoma | Q45399881 | ||
| A phase I/II study of herpes simplex virus type 1 thymidine kinase "suicide" gene therapy for recurrent glioblastoma. Study Group on Gene Therapy for Glioblastoma | Q45752309 | ||
| Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results | Q45863348 | ||
| Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells | Q48587406 | ||
| Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function | Q48661779 | ||
| Phase I study of adenoviral delivery of the HSV-tk gene and ganciclovir administration in patients with current malignant brain tumors. | Q54635100 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Adenoviridae | Q193447 |
| P1104 | number of pages | 10 | |
| P304 | page(s) | 4369-4378 | |
| P577 | publication date | 2015-12-23 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Adenovirus-mediated delivery of herpes simplex virus thymidine kinase administration improves outcome of recurrent high-grade glioma | |
| P478 | volume | 7 |
| Q28469323 | A televised, web-based randomised trial of an herbal remedy (valerian) for insomnia |
| Q47569046 | Advances in immunotherapeutic research for glioma therapy. |
| Q47933340 | Cell-Surface Integrins and CAR Are Both Essential for Adenovirus Type 5 Transduction of Canine Cells of Lymphocytic Origin |
| Q55457323 | Current state of immunotherapy for glioblastoma. |
| Q102063578 | Effects of oncolytic viruses and viral vectors on immunity in glioblastoma |
| Q40060078 | Gene Delivery in Neuro-Oncology |
| Q38654544 | Gene therapy research in Asia |
| Q47553080 | Glioblastoma under Siege: An Overview of Current Therapeutic Strategies. |
| Q45875535 | Immunotherapy and gene therapy as novel treatments for cancer |
| Q57475700 | Immunotherapy for Brain Tumors |
| Q52564518 | Novel Immunotherapeutics for the Treatment of Glioblastoma: The Last Decade of Research. |
| Q97543045 | Suicide gene therapy for the treatment of high-grade glioma: past lessons, present trends, and future prospects |
Search more.